Older Children and Adolescents Living With Perinatally Acquired Human Immunodeficiency Virus Infection

¹ Departments of Pediatrics, Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, National Pediatric & Family HIV Resource Center, Children's Hospital of New Jersey, Newark, St. Vincent's Hospital and Medical Center of New York
² Department of Pediatrics, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, National Pediatric & Family HIV Resource Center, Newwark
³ Children's Hospital of New Jersey, Newark
⁴ Department of Pediatrics, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Children's Hospital of New Jersey, Newark
⁵ Department of Pediatrics, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, National Pediatric, Children's Hospital of New Jersey, Newark
⁶ Department of Pediatrics, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, National Pediatric & Family HIV Resource Center, Children's Hospital of New Jersey, Newark
⁷ Departments of Pediatrics, Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, National Pediatric & Family HIV Resource Center, Children's Hospital of New Jersey, Newark

Objective. To describe the clinical, immunologic, and psychosocial characteristics of children living with perinatally-acquired human immunodeficiency virus (HIV) infection beyond the age of 9 years.

Methods. This is a descriptive cohort study of 42 surviving perinatally infected children older than 9 years followed at the Children's Hospital Acquired Immunodeficiency Syndrome (AIDS) Program (part of a university-based inner city medical center) as of June 1993. The study is based on medical record data of clinical, immunologic, and psychosocial parameters.

Results. The cohort includes 20 boys and 22 girls with a mean age of 136 months. The mean age at diagnosis of HIV infection was 88 months, and 59.5% were asymptomatic at the time of diagnosis. Currently, after a mean follow-up period of 48 months from diagnosis, 23.8% remain asymptomatic, 19.1% have non-AIDS-defining HIV-related symptoms, and 57.1% have AIDS; 85.7% of the cohort did not develop HIV-related symptoms until after 48 months of age (late-onset prolonged survivors). There was an average annual decline of 71.4 CD4+ cells/µL in the cohort from the ages of 7 to 16 years, and 21.4% have a current CD4+ lymphocyte count of greater than 500 cells/µL, 28.6% between 200 and 500 cells/µL, and 50% less than 200 cells/µL; 76% are orphaned as a result of maternal death, with the majority of the cohort (60%) cared for by extended family members. Disclosure of diagnosis has occurred in 57.1%. The vast majority of the cohort (76%) are attending regular school, with the remainder in special education.

Conclusions. Although close to one quarter of the children and adolescents ages 9 to 16 years living with perinatally acquired HIV infection described in this cohort remain asymptomatic and have a relatively intact immune system, the remainder are living with significant HIV-related symptoms, many of which are chronic in nature and have an impact on daily living. The children in this cohort had both significant immunologic deterioration and symptomatic disease progression during the mean follow-up period of 48 months from the time of diagnosis with HIV infection.

This article has been cited by other articles:

				P. Lester, M. Chesney, M. Cooke, P. Whalley, B. Perez, A. Petru, A. Dorenbaum, and D. Wara Diagnostic Disclosure to HIV-Infected Children: How Parents Decide when and what to Tell Clinical Child Psychology and Psychiatry, January 1, 2002; 7(1): 85 - 99. [Abstract] [PDF]

				C. A. Mellins, E. Brackis-Cott, C. Dolezal, A. Richards, S. W. Nicholas, and E. J. Abrams Patterns of HIV Status Disclosure to Perinatally HIV-Infected Children and Subsequent Mental Health Outcomes Clinical Child Psychology and Psychiatry, January 1, 2002; 7(1): 101 - 114. [Abstract] [PDF]

				P. J. Bachanas, K. A. Kullgren, K. S. Schwartz, J. S. McDaniel, J. Smith, and S. Nesheim Psychological Adjustment in Caregivers of School-Age Children Infected With HIV: Stress, Coping, and Family Factors J. Pediatr. Psychol., September 1, 2001; 26(6): 331 - 342. [Abstract] [Full Text] [PDF]

				Committee on Pediatric AIDS Identification and Care of HIV-Exposed and HIV-Infected Infants, Children, and Adolescents in Foster Care Pediatrics, July 1, 2000; 106(1): 149 - 153. [Abstract] [Full Text]

				Treatment Issues for HIV-Positive Adolescents AIDS Clinical Care, March 1, 1999; 1999(301): 1 - 1. [Full Text]

				Committee on Pediatric AIDS Disclosure of Illness Status to Children and Adolescents With HIV Infection Pediatrics, January 1, 1999; 103(1): 164 - 166. [Abstract] [Full Text] [PDF]

				Antiretroviral Therapy and Medical Management of Pediatric HIV Infection Pediatrics, October 1, 1998; 102(4): 1005 - 1062. [Full Text]

				Committee on Pediatric AIDS Surveillance of Pediatric HIV Infection Pediatrics, February 1, 1998; 101(2): 315 - 319. [Abstract] [Full Text] [PDF]

				J. Mok and S. Cooper The needs of children whose mothers have HIV infection Arch. Dis. Child., December 1, 1997; 77(6): 483 - 487. [Abstract] [Full Text]

				J. Cohen, C. Reddington, D. Jacobs, R. Meade, D. Picard, K. Singleton, D. Smith, M. B. Caldwell, A. DeMaria, H.-W. Hsu, et al. School-related Issues Among HIV-Infected Children Pediatrics, July 1, 1997; 100(1): e8 - e8. [Abstract] [Full Text] [PDF]

				K. Nielsen, G. McSherry, A. Petru, T. Frederick, D. Wara, Y. Bryson, N. Martin, C. Hutto, A. J. Ammann, S. Grubman, et al. A Descriptive Survey of Pediatric Human Immunodeficiency Virus-infected Long-term Survivors Pediatrics, April 1, 1997; 99(4): e4 - e4. [Abstract] [Full Text] [PDF]

				M. SHARLAND, D. GIBB, G. TUDOR-WILLIAMS, S. WALTERS, and V. NOVELLI Paediatric HIV infection Arch. Dis. Child., April 1, 1997; 76(4): 293 - 296. [Full Text]